Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Bone. 2008 Mar 15;43(1):162–168. doi: 10.1016/j.bone.2008.03.003

Table 1.

Demographics, Growth, Menarche and Iron Assessment Variables by Subject Diagnosis

Variable THAL (n=152) Tx-SCD (n=203) NonTx-SCD (n=65) p-value (Thal vs. Tx- SCD) p-value (TxSCD vs. NonTx- SCD)

Age, years Mean (SD) 25.5 (8.1) 24.7 (13.2) 25.1 (11.4) NS NS
Subjects, > 18 yrs N (%) 118 (77.6) 101 (49.8) 41 (63.1) <0.001 NS
Male N (%) 80 (52.6) 88 (43.4) 33 (50.7) NS NS
Weight Z-score Mean (SD) −1.1 (1.4) −0.3 (1.3) −0.4 (1.2) <0.001 NS
Height Z-score Mean (SD) −1.6 (1.2) −0.6 (1.3) −0.1 (1.1) <0.001 0.04
Age at Menarche, y c Mean (SD) 14.3 (2.3) 13.9 (2.2) 14.9 (1.9) NS 0.05
Serum Ferritin, ng/mL d Mean (SD) 3605 (2322) 4338 (3013) 108 (83) <0.001 <0.001
Transfusion Duration, y Mean (SD) 21.3 (8.8) 9.8 (7.2) <0.001 --
Range (0.6–42.5) (0.3–40.2) ---
Any Endocrinopathy e % 85 (55.9) 26 (12.8) 5 (7.7) <0.001 NS
a

For continuous variables, p-value for the difference between two groups is based on Student’s t-test. For categorical variables, p-value for the difference between groups is based on Pearson’s chi-square test.

b

BMI= Body Mass Index, kg/m2

c

Age at onset of menarche from only those females who successfully achieved menarche by the time of the baseline evaluation

d

Serum ferritin, is the average of 2 to 3 values analyzed within the previous 12 months. Mean values are provided in the table. Due to the skewness of these data, log transformed values were used in all analyses

e

Any endocrinopathy included evidence of diabetes, growth failure, hypogonadism or hypothyroidism.